Anzemet and Tachypnea - a phase IV clinical study of FDA data


We study 2,574 people who have side effects when taking Anzemet. Tachypnea is found, especially among people who are female, 60+ old, also take Valium and have Stress and anxiety.

The phase IV clinical study analyzes which people take Anzemet and have Tachypnea. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2023

2,574 people reported to have side effects when taking Anzemet.
Among them, 20 people (0.78%) have Tachypnea.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. Currently, eHealthMe is studying from 2,603 Anzemet users.

What is Tachypnea?

Tachypnea is found to be associated with 2,388 drugs and 1,730 conditions by eHealthMe. Currently, we are studying 15,860 people who have Tachypnea.

Number of Anzemet and Tachypnea reports submitted per year:

Could Anzemet cause Tachypnea?

Gender of people who have Tachypnea when taking Anzemet *:

  • female: 95 %
  • male: 5 %

Age of people who have Tachypnea when taking Anzemet *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 35 %
  • 30-39: 0.0 %
  • 40-49: 5 %
  • 50-59: 0.0 %
  • 60+: 60 %

Common drugs people take besides Anzemet *:

  1. Flexeril: 17 people, 85.00%
  2. Valium: 17 people, 85.00%
  3. Protonix: 16 people, 80.00%
  4. Aredia: 12 people, 60.00%
  5. Pepcid: 12 people, 60.00%
  6. Zyrtec: 11 people, 55.00%
  7. Zometa: 11 people, 55.00%
  8. Mobic: 11 people, 55.00%
  9. Neurontin: 11 people, 55.00%
  10. Nexium: 11 people, 55.00%

Common side effects people have besides Tachypnea *:

  1. Stress And Anxiety: 17 people, 85.00%
  2. Arrhythmias (irregular heartbeat): 17 people, 85.00%
  3. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 17 people, 85.00%
  4. Loss Of Consciousness: 15 people, 75.00%
  5. Fall: 12 people, 60.00%
  6. Headache (pain in head): 12 people, 60.00%
  7. Heart Attack: 12 people, 60.00%
  8. Nausea (feeling of having an urge to vomit): 12 people, 60.00%
  9. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 11 people, 55.00%
  10. Fever: 11 people, 55.00%

Common conditions people have *:

  1. Stress And Anxiety: 17 people, 85.00%
  2. Pain In Jaw: 11 people, 55.00%
  3. Multiple Myeloma (cancer of the plasma cells): 11 people, 55.00%
  4. Back Pain: 6 people, 30.00%
  5. Resorption Bone Increased: 1 person, 5.00%
  6. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 5.00%
  7. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Anzemet and have Tachypnea?

Check whether Tachypnea is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Tachypnea and when was it recovered:

Expand to all the drugs that have ingredients of dolasetron mesylate:

Alternative drugs to, pros and cons of Anzemet:

Browse all side effects of Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Tachypnea treatments and more:

Common drugs associated with Tachypnea:

All the drugs that are associated with Tachypnea:

Common conditions associated with Tachypnea:

All the conditions that are associated with Tachypnea:

How the study uses the data?

The study uses data from the FDA. It is based on dolasetron mesylate (the active ingredients of Anzemet) and Anzemet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: